Immunological biomarkers of tuberculosis
Currently there are no sufficiently validated biomarkers to aid the evaluation of new
tuberculosis vaccine candidates, the improvement of tuberculosis diagnostics or the …
tuberculosis vaccine candidates, the improvement of tuberculosis diagnostics or the …
Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of …
DM Lewinsohn, MK Leonard, PA LoBue… - Clinical Infectious …, 2017 - academic.oup.com
Abstract Background. Individuals infected with Mycobacterium tuberculosis (Mtb) may
develop symptoms and signs of disease (tuberculosis disease) or may have no clinical …
develop symptoms and signs of disease (tuberculosis disease) or may have no clinical …
[HTML][HTML] Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection-United States, 2010
GH Mazurek, J Jereb, A Vernon, P LoBue… - MMWR Recomm …, 2010 - cdc.gov
In 2005, CDC published guidelines for using the QuantiFERON-TB Gold test (QFT-
G)(Cellestis Limited, Carnegie, Victoria, Australia)(CDC. Guidelines for using the …
G)(Cellestis Limited, Carnegie, Victoria, Australia)(CDC. Guidelines for using the …
Evidence-based comparison of commercial interferon-γ release assays for detecting active TB: a metaanalysis
R Diel, R Loddenkemper, A Nienhaus - Chest, 2010 - Elsevier
Test accuracy of interferon-γ release assays (IGRAs) for diagnosing TB differs when using
older or precommercial tools and inconsistent diagnostic criteria. This metaanalysis critically …
older or precommercial tools and inconsistent diagnostic criteria. This metaanalysis critically …
Interferon gamma release assays: principles and practice
A Lalvani, M Pareek - Enfermedades infecciosas y microbiologia clinica, 2010 - Elsevier
The last decade has witnessed significant advances in mycobacterial genomics and cellular
research which have resulted in the development of two new blood tests, the enzyme-linked …
research which have resulted in the development of two new blood tests, the enzyme-linked …
Advances in the diagnosis of tuberculosis
C Lange, T Mori - Respirology, 2010 - Wiley Online Library
Tuberculosis ranges among the leading causes of morbidity and mortality worldwide. A
diagnostic approach to a patient with possible tuberculosis includes a detailed medical …
diagnostic approach to a patient with possible tuberculosis includes a detailed medical …
Priorities for screening and treatment of latent tuberculosis infection in the United States
BP Linas, AY Wong, KA Freedberg… - American journal of …, 2011 - atsjournals.org
Rationale: To improve the effectiveness of tuberculosis (TB) control programs in the United
States by identifying cost-effective priorities for screening for latent tuberculosis infection …
States by identifying cost-effective priorities for screening for latent tuberculosis infection …
IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions
The current state-of-the-art tests for infection with Mycobacterium tuberculosis–the IFN-γ
release assays–rely on accurate measurement of the cytokine IFN-γ. Many other potential …
release assays–rely on accurate measurement of the cytokine IFN-γ. Many other potential …
Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report
Background Interferon gamma release assays, including the QuantiFERON® TB Gold In
Tube (QFT) have been shown to be accurate in diagnosing Mycobacterium tuberculosis …
Tube (QFT) have been shown to be accurate in diagnosing Mycobacterium tuberculosis …
[引用][C] Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis
E Petruccioli, TJ Scriba, L Petrone… - European …, 2016 - Eur Respiratory Soc